Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]

Yang X, Hou Z, Zhu K, et al. Cancer Manag Res.  2020;12:3163– 3173. The authors have advised there is an error with Figure 2 on page 3170. The figure parts C-H do not match the description in the figure caption or figure citations throughout the text. Th...

Full description

Bibliographic Details
Main Authors: Yang X, Hou Z, Zhu K, Zhang S, Gu X, Wang Z, Mu H, Zhou H, Chen P, Zhu X, Cui Y, Li Q, Li H, Zhang T
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Cancer Management and Research
Subjects:
htn
hcc
Online Access:https://www.dovepress.com/corrigendum-drug-related-hypertension-associated-with-the-efficacy-of--peer-reviewed-article-CMAR
id doaj-a4fdd7d837e0455388b04dd2b541193f
record_format Article
spelling doaj-a4fdd7d837e0455388b04dd2b541193f2020-11-25T03:11:27ZengDove Medical PressCancer Management and Research1179-13222020-06-01Volume 124169417054274Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]Yang XHou ZZhu KZhang SGu XWang ZMu HZhou HChen PZhu XCui YLi QLi HZhang TYang X, Hou Z, Zhu K, et al. Cancer Manag Res.  2020;12:3163– 3173. The authors have advised there is an error with Figure 2 on page 3170. The figure parts C-H do not match the description in the figure caption or figure citations throughout the text. The authors apologize for this error. Read the original articlehttps://www.dovepress.com/corrigendum-drug-related-hypertension-associated-with-the-efficacy-of--peer-reviewed-article-CMARvegfr-2htnhccresistanceliver cancer.
collection DOAJ
language English
format Article
sources DOAJ
author Yang X
Hou Z
Zhu K
Zhang S
Gu X
Wang Z
Mu H
Zhou H
Chen P
Zhu X
Cui Y
Li Q
Li H
Zhang T
spellingShingle Yang X
Hou Z
Zhu K
Zhang S
Gu X
Wang Z
Mu H
Zhou H
Chen P
Zhu X
Cui Y
Li Q
Li H
Zhang T
Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]
Cancer Management and Research
vegfr-2
htn
hcc
resistance
liver cancer.
author_facet Yang X
Hou Z
Zhu K
Zhang S
Gu X
Wang Z
Mu H
Zhou H
Chen P
Zhu X
Cui Y
Li Q
Li H
Zhang T
author_sort Yang X
title Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]
title_short Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]
title_full Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]
title_fullStr Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]
title_full_unstemmed Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]
title_sort drug-related hypertension associated with the efficacy of apatinib on hepatocellular carcinoma [corrigendum]
publisher Dove Medical Press
series Cancer Management and Research
issn 1179-1322
publishDate 2020-06-01
description Yang X, Hou Z, Zhu K, et al. Cancer Manag Res.  2020;12:3163– 3173. The authors have advised there is an error with Figure 2 on page 3170. The figure parts C-H do not match the description in the figure caption or figure citations throughout the text. The authors apologize for this error. Read the original article
topic vegfr-2
htn
hcc
resistance
liver cancer.
url https://www.dovepress.com/corrigendum-drug-related-hypertension-associated-with-the-efficacy-of--peer-reviewed-article-CMAR
work_keys_str_mv AT yangx drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT houz drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT zhuk drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT zhangs drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT gux drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT wangz drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT muh drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT zhouh drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT chenp drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT zhux drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT cuiy drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT liq drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT lih drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
AT zhangt drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum
_version_ 1724654118893518848